Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab-Reference-Cited by-同舟云学术

Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab

Published:2020-07-15 Issue:1 Volume:5 Page:145-151
ISSN:2472-5625
Container-title:Modern Rheumatology Case Reports
language:en
Short-container-title:Modern Rheumatology Case Reports

Author:

Wakiya Risa¹^ORCID,Kameda Tomohiro¹,Takeuchi Yohei¹,Ozaki Hiroki¹,Nakashima Shusaku¹,Shimada Hiromi¹,Kadowaki Norimitsu¹,Dobashi Hiroaki¹

Affiliation:

1. Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/24725625.2020.1789304

Reference23 articles.

1. Castleman-Kojima Disease (TAFRO Syndrome) : A Novel Systemic Inflammatory Disease Characterized by a Constellation of Symptoms, Namely, Thrombocytopenia, Ascites (Anasarca), Microcytic Anemia, Myelofibrosis, Renal Dysfunction, and Organomegaly : A Status Report and Summary of Fukushima (6 June, 2012) and Nagoya Meetings (22 September, 2012)

2. Atypical Hyaline Vascular-Type Castleman's Disease With Thrombocytopenia, Anasarca, Fever, and Systemic Lymphadenopathy

3. Successful Treatment of a Patient with Multicentric Castleman's Disease who Presented with Thrombocytopenia, Ascites, Renal Failure and Myelofibrosis Using Tocilizumab, an Anti-Interleukin-6 Receptor Antibody

4. Japanese Variant of Multicentric Castleman's Disease Associated With Serositis and Thrombocytopenia ^|^mdash; A Report of Two Cases: Is TAFRO Syndrome (Castleman- Kojima Disease) a Distinct Clinicopathological Entity?

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tacrolimus Treatment for TAFRO Syndrome;Biomedicines;2024-05-12

2. A Case of TAFRO-like Symptoms in a Sjögren's Syndrome Patient with HTLV-1 Infection;Internal Medicine;2024

3. Treatment-resistant idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, renal dysfunction, and organomegaly managed with Janus kinase inhibitors: A case report;Medicine;2022-12-02

4. TAFRO syndrome: A disease that known is half cured;Hematological Oncology;2022-10-03

5. Post-transplant Complication With TAFRO Features in a Patient With Acute Myeloid Leukemia;Cureus;2022-03-31